Oaktree Acquisition Corp. III Life Sciences (OACC) stock
OACCNasdaqBlank ChecksFiscal year ends December 31Also trades as OACCU, OACCW
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026
$10.72+0.02 (+0.19%)
Close on Nov 17, 2026Market cap $263.53MP/E –Yield –
Oaktree Acquisition Corp. III Life Sciences r&d expenses
Research and development expenses are spending on new products and technology.
No r&d expenses figures for Oaktree Acquisition Corp. III Life Sciences
Oaktree Acquisition Corp. III Life Sciences has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.
See a number that looks wrong?